Los Angeles Capital Management
YMAB

Los Angeles Capital Management’s Y-mAbs Therapeutics YMAB Stock Holding History

Los Angeles Capital Management’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,284
Closed -$46.4K – 1559
2025
Q2 		$46.4K Buy
+10,284
New +$46.2K ﹤0.01% 1312
2024
Q2 		– Sell
-127,551
Closed -$2.07M – 1293
2024
Q1 		$2.07M Sell
127,551
-228,979
-64% -$3.09M 0.01% 489
2023
Q4 		$2.43M Buy
356,530
+52,610
+17% +$304K 0.01% 440
2023
Q3 		$1.66M Buy
303,920
+32,994
+12% +$192K 0.01% 496
2023
Q2 		$1.84M Buy
+270,926
New +$2.03M 0.01% 510
2021
Q2 		– Sell
-8,295
Closed -$251K – 1690
2021
Q1 		$251K Sell
8,295
-3,554
-30% -$146K ﹤0.01% 1480
2020
Q4 		$587K Sell
11,849
-125
-1% -$5.78K ﹤0.01% 1142
2020
Q3 		$460K Buy
+11,974
New +$477K ﹤0.01% 1113

Other funds holding YMAB

BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Los Angeles Capital Management's YMAB Position: Q3 2025 in Review

Los Angeles Capital Management sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 10,284 shares — an estimated $46.4K sold.

Los Angeles Capital Management first reported a position in YMAB in Q3 2020 and held it in 8 quarters. The position peaked at $2.43M in Q4 2023. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

  • Los Angeles Capital Management reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Los Angeles Capital Management sold 10,284 Y-mAbs Therapeutics shares in Q3 2025, an estimated $46.4K.
  • Los Angeles Capital Management first reported a position in Y-mAbs Therapeutics in Q3 2020 and held it in 8 quarters.
  • Los Angeles Capital Management's Y-mAbs Therapeutics position peaked at $2.43M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on Los Angeles Capital Management's 13F filing for Q3 2025, filed 20 Oct 2025.